The drug baricitinib (a type of drug known as a Janus kinase (JAK) inhibitor, also used to treat rheumatoid arthritis) is strongly recommended for patients with severe or critical COVID-19 in combination with corticosteroids, says a WHO Guideline Development Group of international experts in The BMJ.
WHO recommends two new drugs to treat patients with COVID-19
January 17, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022